Guided Therapeutics (GTHP) Minority Interest (2010 - 2012)

Guided Therapeutics (GTHP) posted Minority Interest of $104000.0 for Q3 2012, little changed sequentially from $104000.0 in Q2 2012.

Guided Therapeutics (GTHP) Minority Interest (2010 - 2012) Analysis & Trends

Guided Therapeutics has reported Minority Interest for 3 years, with the latest figure at $104000.0 in Q3 2012.

Quarterly Minority Interest changed N/A year-over-year to $104000.0 in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $104000.0 (changed N/A YoY) and the FY2011 annual result came in at $104000.0, changed 0.0% from the prior year.
Minority Interest was little changed at $104000.0 in Q3 2012 per GTHP's latest filing, from $104000.0 in the prior quarter.
Over five years, Minority Interest peaked at $104000.0 in Q4 2010 and troughed at $104000.0 in Q4 2010.
A 3-year average of $104000.0 and a median of $104000.0 in 2010 frame the typical range for Minority Interest.
The widest YoY moves for Minority Interest: up 0.0% in 2011, down 0.0% in 2011.
Over 3 years, Minority Interest stood at $104000.0 in 2010, then changed by 0.0% to $104000.0 in 2011, then changed by 0.0% to $104000.0 in 2012.
According to Business Quant data, Minority Interest over the past three periods registered $104000.0, $104000.0, and $104000.0 for Q3 2012, Q2 2012, and Q1 2012 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Guided Therapeutics	21.24 Mn	21.23 Mn	-

Download Data